1. Allison AC, Byars NE (1986) An adjuvant formulation that selectively elicits the formation of antibodies of protective isotype and cell mediated immunity. J Immunol Methods 95:157–168.
2. Allison AC, Byars NE (1987) Vaccine technology: adjuvants for increased efficiency. Biotech 5:1041–1045.
3. Beisel C, Tanner J, Matsuo T, Thorley-Lawson D, Kezdy F, Keiff E (1985) Two major outer envelope glycoproteins of Epstein-Barr virus encoded by the same gene. J Virol 54:665–674.
4. Biggin M, Farrell PJ, Barrell BG (1984) Transcription and DNA sequence of Gam HIL fragment of B95-8 Epstein-Barr virus. EMBO J 3:1083–1090.
5. Burkitt D (1963) A lymphoma syndrome in tropical Africa. In Richter GW, Epstein MA (eds) International Review of Experimental Pathology. New York, London. Academic Press, Inc, pp. 67–138.